Eczema Drug Restores Nails in Boy With Rare 19-Nail Dystrophy, Case Report Shows
A case report describes a seven-year-old boy with dystrophy of 19 nails and no eczema whose nails nearly normalized after ...
A case report describes a seven-year-old boy with dystrophy of 19 nails and no eczema whose nails nearly normalized after ...
Monoclonal antibody therapy, led by dupilumab, is transforming the treatment of eosinophilic esophagitis in children after decades of limited options.
A 48-week case report describes how the IL-4/IL-13 blocker dupilumab improved atopic dermatitis, asthma and eosinophilic esophagitis in a seven-year-old ...
A large real-world study of Medicare beneficiaries found mepolizumab matched dupilumab for preventing asthma hospitalizations and significantly reduced exacerbation rates, ...
A new meta-analysis of 11 randomized trials shows dupilumab and nemolizumab deliver robust itch and lesion relief in prurigo nodularis, ...
A new systematic review of 172 patients finds that dupilumab, omalizumab, and JAK inhibitors can meaningfully control severe atopic disease ...
A genetically confirmed case of Costello syndrome shows that the biologic drug dupilumab resolved severe, treatment-refractory eczema within one month, ...
A new review argues that chronic spontaneous urticaria needs validated prognostic tools combining clinical features, patient-reported scores, and biomarkers such ...
A new case series and literature review suggest the interleukin-4 and interleukin-13 blocker dupilumab may bring relief to patients with ...
Researchers have built vascularized, immune-integrated human skin assembloids from stem-cell-derived organoids that model atopic dermatitis-like inflammation and respond to approved ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine